Embed Size (px)
Citation preview
Founded in 1992, Health Advances is a leading healthcare strategy firm advising
clients in the biopharma, diagnostic, device, and healthcare services sectors, as
well as investors and non-profit organizations. Healthcare executives rely on
our professionals to help them make confident decisions involving the greatest
challenges in the commercialization of medical technologies and services
throughout the world.
Contact: Sheela [email protected]
Susan [email protected]
BostonSan FranciscoWashington DCZurich
781-647-3435
www.healthadvances.com
www.healthadvances.com
Pioneers inCardiovascular
CommercializationStrategy
Core Competencies
y Business and Product Strategy
y Clinical Trial Strategies
y Forecasting
y Health Economic Analysis
y Market Assessment
y Portfolio Planning
y Pricing and Reimbursement
y Product Launch Planning
y Product Positioning
y Sales and Marketing Strategy
y Transaction Due Diligence
Experience. It’s What Sets Us Apart.
Operating at the intersection of science, technology, and business strategy, Health Advances provides clients with innovative solutions based
on deep industry insight, analytical rigor, and an objective perspective. Example projects include:
Interventional Cardiology
y Product portfolio strategy for leading
interventional cardiology company
y Market assessment for percutaneous
valve replacements
y Due diligence of mid-sized
interventional cardiology company
y Market evaluation for percutaneous
PFO closure device
y Strategic assessment of drug-device
convergence opportunity
y Litigation support for atherectomy
product company
y Partner assessment for novel drug
coating for stents and balloons
Therapeutics & Diagnostics
y Market assessment for a novel IV
antiplatelet therapy
y Commercialization strategy for
adenosine A1 receptor antagonist
y Worldwide revenue forecast for
endothelin receptor antagonist (ERA)
y Opportunity assessment for
synthetic heparin alternative
y Due diligence on nuclear stress
testing imaging agent
y Customer segmentation analysis
for Phase III radiopharmaceutical
y Commercialization strategy for
improved EKG
Peripheral Vascular Interventions
y Clinical development strategy
for AAA stent graft
y Opportunity prioritization for
mechanical thrombus ablation system
y Pricing and reimbursement strategy
for stroke clot retrieval device
y Strategic analysis of US PICCs
and ports market
y Assessment of the aneurysm
coil market
y Due diligence on early-stage
vascular device company
y Assessment of alternative approaches
to treat SFA occlusions
Cardiac Surgery & Electrophysiology
y Sales forecast for enhanced
cardiopulmonary bypass machine
y Future competitive landscape and
market forecast for LVADs
y Due diligence on surgical atrial
fibrillation ablation company
y Assessment of tissue-based and
mechanical-based valve markets
y Market evaluation for novel
ICD/CRT-D technology
y Pharmacoeconomic analysis for
EP monitoring device
y Market assessment of cryoablation
for atrial fibrillation
www.healthadvances.com
